| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-813 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
1990-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c4c07677f49afd9295bc9e9ec82ce5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e86208d3b11025afdf259ff41849fc12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a32c173cb9f12a9e45ff3e5cb6851d91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37eb517d0816bb4da61184a66e601879 |
| publicationDate |
1990-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9014595-A1 |
| titleOfInvention |
Composition and method to detect sensitivity to alpha interferon therapy |
| abstract |
This invention provides the hybridoma designated F 33 (ATCC No. HB 10155) and the monoclonal antibody produced by it. This invention also provides a method of detecting the sensitivity of a malignant cell or tissue to alpha interferon therapy which comprises contacting a sample of the malignant cell or tissue with a monoclonal antibody which recognizes an epitope of gp 160 cell surface antigen under conditions such that an antibody-antigen complex is formed between the monoclonal antibody and the gp 160 cell surface antigen, if the antigen is present in the sample; and detecting any complex so formed, the absence of complex indicating that the malignant cell or tissue is sensitive to alpha interferon therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5990287-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5990297-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5767246-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0520499-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5837845-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6787153-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7074613-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6139869-A |
| priorityDate |
1989-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |